Alcohol alternatives – a goal for psychopharmacology?

Foresight (2005) ‘Brain Science Addiction and Drugs’, see www.foresight.com

Gonzalez A , Nutt D J (2005) Gammahydroxybutyrate (GHB) abuse and dependency . Journal of Psychopharmacology 19(2): 195–204

Law F , Daglish M R C , Myles J S , Nutt D J (2004) The clinical use of buprenorphine in opiate addiction: evidence and practice . Acta Neuropsychiatrica 16: 246–274

Lingford-Hughes A , Nutt D (2003) Neurobiology of addiction and implications for treatment . Br J Psychiatry 182: 97–100

Lingford-Hughes A , Welch S , Nutt D J (2004) Evidence based guidelines for the pharmacological management of substance misuse, addiction and company-morbidity . Journal of Psychopharmacology 18: 293–335

Nutt D J (2005) Making sense of GABA-A receptor subtypes – is a new nomenclature needed? Journal of Psychopharmacology 19(3): 219–220

Nutt D J , Malizia A L (2001) New insights into the role of the GABA(A)benzodiazepine receptor in psychiatric disorder . Br J Psychiatry 179: 390–396

Potokar J , Nutt D J (1994) Anxiolytic potential of benzodiazepine receptor partial agonists . CNS Drugs 1: 305–315

Room R , Babor T , Rehm J (2005) Alcohol and public health . Lancet 365(9458): 519–530

Sundstrom-Paromaa I , Smith D H , Gong Q H , Sabado T N , Li X , Light A , Wiedmann M , Williams K , Smith S S (2002) Hormonally regulated a4b2d receptors are a target for ethanol . Nature Neuroscience 5: 721–722

Swanson C J , Bures M , Johnson M P , Linden A-M , Monn J A , Schoepp D D (2005) Metabotropic glutamate receptors as novel targets for anxiety and stress disorders . Nature Reviews Drug Discovery 4: 131–144